Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials.
Ishikawa T, Ogawa T, Shiihara M, Usubuchi H, Omori Y, Hirose K, Itoh T, Yoshida T, Nakanome A, Okoshi A, Higashi K, Ishii R, Rokugo M, Wakamori S, Okamura Y, Kinoshita K, Katori Y, Furukawa T.
Ishikawa T, et al. Among authors: furukawa t.
iScience. 2023 Apr 20;26(5):106695. doi: 10.1016/j.isci.2023.106695. eCollection 2023 May 19.
iScience. 2023.
PMID: 37207275
Free PMC article.